African

• The SDG Impact Fund and Apierion Impact Fund believe that humanity must transition into Regenerative Global Solutions that are adaptable, inclusive, and honorable — where no one is left behind.
• The SDG Impact Fund and Apierion Impact Fund are committed to mobilizing the world's largest asset and capital resources to achieve prosperity for all.
• "The Apierion Impact Fund is proud to be a component of the SDG Impact Fund, and we hope to propel our philanthropic efforts to new heights by joining forces," added Atif Bostic, Chief Executive Officer of The Apierion Impact Fund.
• Atif Bostic is the newly named Executive Director and Lead Impact Steward of The Apierion Impact Fund.

• The largest components of the South African social grant system were introduced, or expanded to include the full population, in the 1990s.
• Since then, the system has evolved into one of the most comprehensive in the global south.
• In addition to their direct financial benefits, the grants have been found to have a wide range of positive effects.
• Across a series of recent studies conducted as part of an extensive research project in a rural part of South Africa, we have established that social grants can help older South Africans protect their cognitive health and live longer.

How we did the studies and what we learnt

• This rural campus of the University of the Witwatersrand was established to track and understand health and well-being in these rural environments.
• The Agincourt project is also a platform for other studies to collect more detailed information on certain community members.
• We also used data from Health and Aging in Africa: Longitudinal Studies in South Africa.
• In a second study we examined the impact of the older person’s grant, a public pension, on men’s later-life cognitive health.
• We also observed a “stair step” pattern, where cognitive function was progressively better for each extra year of pension eligibility.

Looking forward

Our results so far clearly point to the benefits of South Africa’s social grant programmes for older adults as they are currently structured. They suggest that as South Africa ages in the upcoming decades, sustained investments in these programmes will pay off in better health and well-being of the country’s most vulnerable older adults.
Molly Rosenberg receives funding from the United States National Institute on Aging of the National Institutes of Health (grant number R01AG069128) Lindsay Kobayashi is supported by the National Institute on Aging of the US National Institutes of Health (grant numbers R01 AG069128 and R01 AG070953).
Chodziwadziwa Whiteson Kabudula and Kathleen Kahn do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

• HANOVER, Md., Feb. 5, 2024 /PRNewswire-PRWeb/ -- Major, Lindsey & Africa (MLA), the world's leading legal search firm, announced today its new professional leadership development experience, MLAccelerate.
• Each module focuses on a different competency, but all sessions incorporate a continuous theme of identity-based leadership development.
• Most notably, the program will incorporate a robust sponsorship component incorporating the firm's most successful recruiters as committed champions for the development and success of program participants.
• Future iterations of the program will be expanded to include members of the firm's other ERGs.

• Commencement of Direct Sales Operations in Africa, and Establishment of Branch Office in Kenya
  TOKYO, Feb 1, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that fully-fledged operations have begun at Eisai Pharmaceuticals Africa (Pty) Ltd ("Eisai South Africa"), a pharmaceutical sales subsidiary recently established in Johannesburg, South Africa, and direct sales operations and business activities have commenced in Africa.
• Eisai South Africa is a wholly-owned subsidiary of Eisai.
• Eisai South Africa has started sales and marketing activities directly for Lenvima and Fycompa from January 2024, as well as Halaven from February 2024.
• Seeking solutions to these challenges in Africa, Eisai will continue its initiatives to deliver necessary medicines to the patients who need them through Eisai South Africa and Eisai Kenya.